Sat-18-12-2021, 22:10 PM
|
Rinvoq goes for psoriatic arthritis approval
|
|
Thu-13-01-2022, 14:27 PM
Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.
Mon-17-01-2022, 21:12 PM
(Thu-13-01-2022, 14:27 PM)Fred Wrote: Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.I'll keep my head down and hope it's never offered me as an option
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
|
Association of lifestyle related factors and psoriatic arthritis | Fred | 3 | 163 |
Yesterday, 19:03 PM Last Post: Caroline |
|
|
Reducing the risk of psoriatic arthritis | Fred | 3 | 643 |
Mon-27-04-2026, 10:07 AM Last Post: Waine |
|
|
Psoriatic arthritis and GLP-1RA therapy | Fred | 7 | 1,664 |
Fri-10-04-2026, 16:32 PM Last Post: mataribot |
|
|
Radiographic structural damage & psoriatic arthritis | Fred | 0 | 559 |
Sat-21-03-2026, 13:21 PM Last Post: Fred |
|
|
Icotrokinra seeks approval for psoriasis | Fred | 7 | 3,508 |
Fri-20-03-2026, 06:30 AM Last Post: mataribot |
Users browsing this thread: 1 Guest(s)


Health Boards